Founded
Address
Bay City Capital LLC
750 Battery Street
Suite 400
San Francisco, CA 94111
United States
Phone
Website
Recent investment activity
KANDO id: 2637
Corporate information
Registration country
Funding rounds
Actual initial investment stage
N/A (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 64| Company | Profile | Country | Funding | ||
|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Aciex Therapeutics Inc | Specialty pharmaceutical company focused on the development of therapeutics to treat front of the eye diseases. | N/A | ||
|
|
Amerifit Nutrition Inc | Develops, sources, markets, and sells branded nutritional supplement products, targeting select consumer growth segments. | N/A | ||
|
|
Aquabounty Technologies Inc | Develops innovative technologies to significantly improve the economics and productivity of fish farming. | N/A | ||
|
|
Aviir Inc | Assists in the prevention of cardiovascular disease and management of related conditions by delivering innovative cardiometabolic tests and associated | N/A | ||
|
|
Bioren Inc | Antibody discovery and optimization company developing a rational approach to antibody engineering. | N/A | ||
|
|
BioSeek Inc | Improving the success rate of pharmaceutical research and development by integrating human biology from the earliest stages of drug discovery onward. | N/A | ||
|
|
BrainCells Inc | A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. | N/A | ||
|
|
Cadence Pharmaceuticals Inc | Focused on in-licensing, developing, and commercializing proprietary product candidates principally for use in the hospital setting. | N/A | ||
|
|
Chemdex | Internet clearinghouse to facilitate the distribution of specialty chemicals, biochemicals, and reagents. | N/A | ||
|
|
Conatus Pharmaceuticals Inc | Biotechnology company focused on the development of innovative human therapeutics to treat liver disease and cancer. | N/A | ||
|
|
Dermira Inc | Specialty pharmaceutical company with the goal of establishing a presence in the dermatology space by acquiring marketed products and a pipeline of la | N/A | ||
|
|
EnteroMedics Inc | Develops therapeutic devices for the treatment of obesity. Its VSM technology uses electrical signals, delivered by an implantable electrode array, to | N/A | ||
|
|
Eos Biotechnology Inc | Next generation genomics company that uses the complete human genome to identify new drug targets and develop antibodies against those targets to trea | N/A | ||
|
|
Epizyme Inc | Focusing on the discovery and development of innovative drugs targeting epigenetic enzymes, in particular histone methyltransferases (HMTs). | N/A | ||
|
|
Epoch Biosciences Inc | Biotech company focused on development and commercialization of proprietary nucleic acid chemistries for research and diagnostic applications. | N/A | ||
|
|
Epocrates Inc | Largest mobile computing network for physicians using hand-held PDA device. | N/A | ||
|
|
GenturaDx-USA Inc | Molecular diagnostic company focused on making multiplexed molecular testing both affordable and practical for any laboratory to perform. | N/A | ||
|
|
Hyperion Therapeutics Inc | Hyperion Therapeutics is a privately held specialty pharmaceutical company focused on the development of therapies that address critical unmet needs i | N/A | ||
|
|
IDEV Technologies Inc | Developer of next generation medical devices for use in the interventional radiology, vascular surgery, and cardiology device marketplace. | N/A | ||
|
Intarcia Therapeutics Inc | A biopharmaceutical company applying a targeted approach to the acquisition, development and commercialization of novel therapeutic products for the t | N/A | ||
|
|
Itamar Medical Ltd | Develops a minimally invasive diagnostic that measures through a finger probe the Peripheral Arterial Tone (PAT) signal. | N/A | ||
|
|
Lexicon Pharmaceuticals Inc | Designs and develops high throughput mutagenesis technologies for studying functional genomics in mammalian systems. | N/A | ||
|
|
LJL BioSystems Inc | Proprietary instrumentation and consumables for high throughput and ultra-high throughput screening for drug discovery. | N/A | ||
|
|
Madrigal Pharmaceuticals Inc | Drug development company focused on building a pipeline of small-molecule drugs for the treatment of cardiovascular and metabolic diseases. | N/A | ||
|
|
MAP Pharmaceuticals Inc | Proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs. | N/A |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Lionel Carnot | Investment Partner (past)
|
[email protected] | ||
| Fred Craves | [email protected] | |||
| Carl Goldfischer | [email protected] | |||
| Manuel López-Figueroa | Vice President (past)
|
|||
| Dayton Misfeldt | Investment Partner (past)
|
[email protected] | ||
| Susan Vuong |
Former team members
| Employee | Company | Position | ||
|---|---|---|---|---|
| Min Cui | Decheng Capital | |||
| Min Cui | GeneWeave Biosciences Inc |